Skip main navigation

Overview of this week


What can you expect to learn from this week? Professor Daniel Brown is going to explain the topic: The Challenges of Assessing Renal and Hepatic Clearance

Summary of Week 4:

1. Differences between drug elimination via filtration and biotransformation.
2. How renal function can be estimated based on creatinine clearance (CLCr) or GFR, for purposes of adjusting drug dosing.
3. How to correct (CLCr) or GFR to a standard body size.
4. The inherent sources of error associated with the Cockcroft-Gault equation that relate to body weight and muscle mass.
5. How the hepatic first-pass effect impacts drug bioavailability.
6. Hepatic extraction and the difference between High E and Low E drug clearance.
7. How hepatic clearance is affected by QH, CLint, and fu, and also how those factors affect Css, CU, and bioavailability.

We hope you enjoy.

This article is from the free online

Clinical Pharmacokinetics: Dosing and Monitoring

Created by
FutureLearn - Learning For Life

Our purpose is to transform access to education.

We offer a diverse selection of courses from leading universities and cultural institutions from around the world. These are delivered one step at a time, and are accessible on mobile, tablet and desktop, so you can fit learning around your life.

We believe learning should be an enjoyable, social experience, so our courses offer the opportunity to discuss what you’re learning with others as you go, helping you make fresh discoveries and form new ideas.
You can unlock new opportunities with unlimited access to hundreds of online short courses for a year by subscribing to our Unlimited package. Build your knowledge with top universities and organisations.

Learn more about how FutureLearn is transforming access to education